(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Earnings Watch: Agilent, Symbotic, and Legend Biotech Set to Unveil

  • November 18th, 2023
  • 390 views

On Monday, November 20, several companies are slated to unveil their financial results, including:

Agilent Technologies Inc. (NYSE: A), a leader in life sciences, diagnostics, and applied chemical markets, will release financial results for the fourth quarter of fiscal year 2023 after the stock market closes. 

Analysts project earnings per share (EPS) of $1.35 on revenue amounting to $1.67 billion.

$A closed at $113.15 on Friday, down $1.04 (-0.91%).

Symbotic Inc. (Nasdaq: SYM), a robotics and automation company, is set to release its fourth quarter and fiscal year 2023 financial results after the market close. 

The consensus estimate points to a loss of $0.12 per share, with revenue reaching $306.9 million.

On Friday, $SYM closed at $37.20, up $1.21 (+3.36%).

Legend Biotech Corporation (Nasdaq: LEGN), a biotechnology company, is gearing up to report its third-quarter 2023 financial results before the market opens. 

Analysts are forecasting a loss of $0.59 per share on revenue totaling $97.28 million.

$LEGN closed at $64.56 on Friday, reflecting an increase of $0.98 (+1.54%).

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)

Social Shares

Post Your Comments


Warning: Undefined array key "hashid" in /var/www/html/subs/visit_counter.php on line 13